1. Home
  2. ECOR vs SRFM Comparison

ECOR vs SRFM Comparison

Compare ECOR & SRFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECOR
  • SRFM
  • Stock Information
  • Founded
  • ECOR 2005
  • SRFM 2011
  • Country
  • ECOR United States
  • SRFM United States
  • Employees
  • ECOR N/A
  • SRFM N/A
  • Industry
  • ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SRFM Transportation Services
  • Sector
  • ECOR Health Care
  • SRFM Consumer Discretionary
  • Exchange
  • ECOR Nasdaq
  • SRFM Nasdaq
  • Market Cap
  • ECOR 50.1M
  • SRFM 58.2M
  • IPO Year
  • ECOR 2018
  • SRFM 2023
  • Fundamental
  • Price
  • ECOR $6.11
  • SRFM $3.95
  • Analyst Decision
  • ECOR Strong Buy
  • SRFM Buy
  • Analyst Count
  • ECOR 2
  • SRFM 4
  • Target Price
  • ECOR $25.50
  • SRFM $5.56
  • AVG Volume (30 Days)
  • ECOR 71.2K
  • SRFM 13.7M
  • Earning Date
  • ECOR 08-06-2025
  • SRFM 08-13-2025
  • Dividend Yield
  • ECOR N/A
  • SRFM N/A
  • EPS Growth
  • ECOR N/A
  • SRFM N/A
  • EPS
  • ECOR N/A
  • SRFM N/A
  • Revenue
  • ECOR $26,458,000.00
  • SRFM $112,307,000.00
  • Revenue This Year
  • ECOR $23.21
  • SRFM N/A
  • Revenue Next Year
  • ECOR $44.10
  • SRFM $54.32
  • P/E Ratio
  • ECOR N/A
  • SRFM N/A
  • Revenue Growth
  • ECOR 41.54
  • SRFM 31.17
  • 52 Week Low
  • ECOR $4.47
  • SRFM $0.90
  • 52 Week High
  • ECOR $19.49
  • SRFM $6.72
  • Technical
  • Relative Strength Index (RSI)
  • ECOR 62.63
  • SRFM 64.64
  • Support Level
  • ECOR $5.13
  • SRFM $3.30
  • Resistance Level
  • ECOR $5.69
  • SRFM $4.16
  • Average True Range (ATR)
  • ECOR 0.42
  • SRFM 0.79
  • MACD
  • ECOR 0.09
  • SRFM 0.17
  • Stochastic Oscillator
  • ECOR 91.27
  • SRFM 61.32

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

About SRFM Surf Air Mobility Inc.

Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.

Share on Social Networks: